Bio-Neuroscience 2025 - the premier summit of global innovation, investment and partnering for CNS Neuroscience Drug Development. Featuring a stellar lineup of KOLs, experts, CEOs, investors, industry leaders & decision makers. We are delighted to announce that Stevin Zorn, President & CEO - MindImmune Therapeutics, will join us as a Speaker! Are YOU a stakeholder, serious about CNS Neuroscience Drug Development? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Register & Find out more at https://lnkd.in/eJcBGZ2t #BioNeuroscience #Neuroscience #Neuropharma
Broadreach Global
生物技术研究
Accelerating Innovation. Together. The true potential of most innovation is never realized. Let's change that.
关于我们
Broadreach Global's mission is to accelerate breakthrough technologies to benefit human health, with a particular focus on CNS neurosciences in biopharma drug development, neurotech and neuro digital health, as well as advanced bio-manufacturing as a key field of enabling technology. Identifying world-class innovation and connecting companies with the expertise, investors and strategic partners needed to complete the value chain and translate science?and engineering?into meaningful impact and successful growth companies. With a unique global pipeline and network, Broadreach Global advises companies, funds, advises governments and institutions on innovation policy, and supports technology transfer offices, entrepreneurs and companies on strategy and business development.
- 网站
-
https://www.broadreach-global.com/
Broadreach Global的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Miami
- 类型
- 私人持股
地点
-
主要
获取路线
US，Miami
Broadreach Global员工
-
Christian Suojanen
CEO / Broadreach Global, Startup Advisor, & Board Member / European Brain Foundation.
-
Wael Roshdi
MSc/MBA Candidate | Biotech and Deep Tech Enthusiast | Empowering Innovators through Sales and Marketing Strategies
-
Emi Kapetangiannis
Aspiring Neuroscientist & Innovator | Neuroscience Communications Coordinator @ Broadreach Global | Seeking Undergraduate Internships (Jun - Dec…
动态
-
Bio-Neuroscience 2025 - the premier summit of global innovation, investment and partnering for CNS Neuroscience Drug Development. Featuring a stellar lineup of KOLs, experts, CEOs, investors, industry leaders & decision makers. We are delighted to announce that Klaus Dugi, CEO - Vandria SA, will join us as a Speaker! Are YOU a stakeholder, serious about CNS Neuroscience Drug Development? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Register & Find out more at https://lnkd.in/eJcBGZ2t #BioNeuroscience #Neuroscience #Neuropharma
-
-
Bio-Neuroscience 2025 - the premier summit of global innovation, investment and partnering for CNS Neuroscience Drug Development. Featuring a stellar lineup of KOLs, experts, CEOs, investors, industry leaders & decision makers. We are delighted to announce that Nawal Roy, Founder & CEO - Holmusk, will join us as a Speaker! Are YOU a stakeholder, serious about CNS Neuroscience Drug Development? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Register & Find out more at https://lnkd.in/eJcBGZ2t #BioNeuroscience #Neuroscience #Neuropharma
-
-
Bio-Neuroscience 2025 - the premier summit of global innovation, investment and partnering for CNS Neuroscience Drug Development. Featuring a stellar lineup of KOLs, experts, CEOs, investors, industry leaders & decision makers. We are delighted to announce that Jacopo Andreose, CEO - Angelini Pharma S.p.A., will join us as a Speaker! Are YOU a stakeholder, serious about CNS Neuroscience Drug Development? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Register & Find out more at https://lnkd.in/eJcBGZ2t #BioNeuroscience #Neuroscience #Neuropharma
-
-
Bio-Neuroscience 2025 - The premier summit of global innovation, investment, and partnerships in CNS Neuroscience Drug Development. Join the top organizations in CNS Neuroscience Drug Development, with CEO and decision-maker level representation already confirmed. Don’t miss out on this unique opportunity to network and collaborate with the industry’s leading minds. Are you a key stakeholder? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Find out more at https://lnkd.in/eJcBGZ2t Andrea Soto Padilla Pieter van Bokhoven Graham Combe Vandria SA MindImmune Therapeutics, Inc. Karuna Therapeutics Eli Lilly and Company Merck Beckman Coulter Life Sciences Catalent Pharma Solutions Julius Clinical Dolby Family Ventures F-Prime Capital M Ventures Angelini Ventures UCB Ventures Lundbeck Lundbeckfonden / Lundbeck Foundation Neurvati Neurosciences Ysios Capital Asabys Partners Muna Therapeutics Kynexis Boehringer Ingelheim European College of Neuropsychopharmacology (ECNP) European Brain Council Cima Universidad de Navarra Denali Therapeutics Merck KGaA, Darmstadt, Germany EQT Life Sciences Holmusk IMAGE ANALYSIS GROUP Juan Carlos Lopez Kalpana Merchant
-
Bio-Neuroscience 2025 - the premier summit of global innovation, investment and partnering for CNS Neuroscience Drug Development. Featuring a stellar lineup of KOLs, experts, CEOs, investors, industry leaders & decision makers. We are delighted to announce that Raúl Martín-Ruiz, Partner - Ysios Capital, will join us as a Speaker! Are YOU a stakeholder, serious about CNS Neuroscience Drug Development? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Register & Find out more at?https://lnkd.in/eJcBGZ2t #BioNeuroscience?#Neuroscience?#Neuropharma
-
-
Bio-Neuroscience 2025 - the premier summit of global innovation, investment and partnering for CNS Neuroscience Drug Development. Featuring a stellar lineup of KOLs, experts, CEOs, investors, industry leaders & decision makers. We are delighted to announce that Thomas Michael Thestrup, Senior Principal - Angelini Ventures will join us as a Speaker! Are YOU a stakeholder, serious about CNS Neuroscience Drug Development? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Register & Find out more at?https://lnkd.in/eJcBGZ2t #BioNeuroscience?#Neuroscience?#Neuropharma
-
-
Bio-Neuroscience 2025 - the premier summit of global innovation, investment and partnering for CNS Neuroscience Drug Development. Featuring a stellar lineup of KOLs, experts, CEOs, investors, industry leaders & decision makers. We are delighted to announce that Steven Biesmans, Principal - UCB Ventures, will join us as a Speaker! Are YOU a stakeholder, serious about CNS Neuroscience Drug Development? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Register & Find out more at?https://lnkd.in/eJcBGZ2t #BioNeuroscience?#Neuroscience?#Neuropharma
-
-
Bio-Neuroscience 2025 - the premier summit of global innovation, investment and partnering for CNS Neuroscience Drug Development. Featuring a stellar lineup of KOLs, experts, CEOs, investors, industry leaders & decision makers. We are delighted to announce that Clara Campàs, Managing Partner & Co-Founder - Asabys Partners, will join us as a Speaker! Are YOU a stakeholder, serious about CNS Neuroscience Drug Development? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Register & Find out more at?https://lnkd.in/eJcBGZ2t #BioNeuroscience?#Neuroscience?#Neuropharma
-
-
Bio-Neuroscience 2025 - the premier summit of global innovation, investment and partnering for CNS Neuroscience Drug Development. Featuring a stellar lineup of KOLs, experts, CEOs, investors, industry leaders & decision makers. We are delighted to announce that Philip Scheltens, Head, Dementia Fund, Partner - EQT Life Sciences, will join us as a Speaker! Are YOU a stakeholder, serious about CNS Neuroscience Drug Development? Register now and save up to €400 with Early Registration. Secure your spot before it’s too late! Amsterdam, 25 - 27 February. An initiative of Broadreach Global, co-organized with host partner Amsterdam UMC - Amsterdam Neuroscience. Register & Find out more at?https://lnkd.in/eJcBGZ2t #BioNeuroscience?#Neuroscience?#Neuropharma Andrea Soto Padilla Pieter van Bokhoven
-